IBDEI15V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20491,1,4,0)
 ;;=4^Raynaud's Syndrome
 ;;^UTILITY(U,$J,358.3,20491,1,5,0)
 ;;=5^443.0
 ;;^UTILITY(U,$J,358.3,20491,2)
 ;;=^103165
 ;;^UTILITY(U,$J,358.3,20492,0)
 ;;=444.21^^109^1267^96
 ;;^UTILITY(U,$J,358.3,20492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20492,1,4,0)
 ;;=4^Upper Extremity Embolism
 ;;^UTILITY(U,$J,358.3,20492,1,5,0)
 ;;=5^444.21
 ;;^UTILITY(U,$J,358.3,20492,2)
 ;;=^269789
 ;;^UTILITY(U,$J,358.3,20493,0)
 ;;=444.22^^109^1267^58
 ;;^UTILITY(U,$J,358.3,20493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20493,1,4,0)
 ;;=4^Lower Extremity Embolism
 ;;^UTILITY(U,$J,358.3,20493,1,5,0)
 ;;=5^444.22
 ;;^UTILITY(U,$J,358.3,20493,2)
 ;;=^269790
 ;;^UTILITY(U,$J,358.3,20494,0)
 ;;=451.11^^109^1267^72
 ;;^UTILITY(U,$J,358.3,20494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20494,1,4,0)
 ;;=4^Phleb/Thrombophl Fem V Deep
 ;;^UTILITY(U,$J,358.3,20494,1,5,0)
 ;;=5^451.11
 ;;^UTILITY(U,$J,358.3,20494,2)
 ;;=^269811
 ;;^UTILITY(U,$J,358.3,20495,0)
 ;;=451.19^^109^1267^45
 ;;^UTILITY(U,$J,358.3,20495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20495,1,4,0)
 ;;=4^Deep Phlebitis,Leg NEC
 ;;^UTILITY(U,$J,358.3,20495,1,5,0)
 ;;=5^451.19
 ;;^UTILITY(U,$J,358.3,20495,2)
 ;;=^269812
 ;;^UTILITY(U,$J,358.3,20496,0)
 ;;=451.81^^109^1267^52
 ;;^UTILITY(U,$J,358.3,20496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20496,1,4,0)
 ;;=4^Iliac Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,20496,1,5,0)
 ;;=5^451.81
 ;;^UTILITY(U,$J,358.3,20496,2)
 ;;=^269814
 ;;^UTILITY(U,$J,358.3,20497,0)
 ;;=454.0^^109^1267^55
 ;;^UTILITY(U,$J,358.3,20497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20497,1,4,0)
 ;;=4^Leg Varicosity w/ Ulcer
 ;;^UTILITY(U,$J,358.3,20497,1,5,0)
 ;;=5^454.0
 ;;^UTILITY(U,$J,358.3,20497,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,20498,0)
 ;;=454.1^^109^1267^54
 ;;^UTILITY(U,$J,358.3,20498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20498,1,4,0)
 ;;=4^Leg Varicosity w/ Inflam
 ;;^UTILITY(U,$J,358.3,20498,1,5,0)
 ;;=5^454.1
 ;;^UTILITY(U,$J,358.3,20498,2)
 ;;=^125435
 ;;^UTILITY(U,$J,358.3,20499,0)
 ;;=454.2^^109^1267^97
 ;;^UTILITY(U,$J,358.3,20499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20499,1,4,0)
 ;;=4^Varicose Leg Ulcer/Inflam
 ;;^UTILITY(U,$J,358.3,20499,1,5,0)
 ;;=5^454.2
 ;;^UTILITY(U,$J,358.3,20499,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,20500,0)
 ;;=454.9^^109^1267^18
 ;;^UTILITY(U,$J,358.3,20500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20500,1,4,0)
 ;;=4^Asymptomatic Varicose Veins
 ;;^UTILITY(U,$J,358.3,20500,1,5,0)
 ;;=5^454.9
 ;;^UTILITY(U,$J,358.3,20500,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,20501,0)
 ;;=459.81^^109^1267^100
 ;;^UTILITY(U,$J,358.3,20501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20501,1,4,0)
 ;;=4^Venous Insufficiency NOS
 ;;^UTILITY(U,$J,358.3,20501,1,5,0)
 ;;=5^459.81
 ;;^UTILITY(U,$J,358.3,20501,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,20502,0)
 ;;=457.1^^109^1267^59
 ;;^UTILITY(U,$J,358.3,20502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20502,1,4,0)
 ;;=4^Lymphedema,Other
 ;;^UTILITY(U,$J,358.3,20502,1,5,0)
 ;;=5^457.1
 ;;^UTILITY(U,$J,358.3,20502,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,20503,0)
 ;;=593.81^^109^1267^76
 ;;^UTILITY(U,$J,358.3,20503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20503,1,4,0)
 ;;=4^Renal Vascular Disorder
 ;;^UTILITY(U,$J,358.3,20503,1,5,0)
 ;;=5^593.81
 ;;^UTILITY(U,$J,358.3,20503,2)
 ;;=^270382
 ;;^UTILITY(U,$J,358.3,20504,0)
 ;;=557.0^^109^1267^9
 ;;^UTILITY(U,$J,358.3,20504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20504,1,4,0)
 ;;=4^AC Vasc Insuff Intestine
 ;;^UTILITY(U,$J,358.3,20504,1,5,0)
 ;;=5^557.0
 ;;
 ;;$END ROU IBDEI15V
